We investigated the ability of compounds interfering with iron metabolism to inhibit the growth of Acinetobacter baumannii. Iron restriction with transferrin or 2,2-bipyridyl significantly inhibited A. baumannii growth in vitro. Gallium nitrate alone was moderately effective at reducing A. baumannii growth but became bacteriostatic in the presence of serum or transferrin. More importantly, gallium nitrate treatment reduced lung bacterial burdens in mice. The use of gallium-based therapies shows promise for the control of multidrug-resistant A. baumannii. Copyright \ua9 2012, American Society for Microbiology. All Rights Reserved.Peer reviewed: YesNRC publication: Ye
There are only few drugs available to treat fungal infections, and the lack of new antifungals, alon...
The activities of iron chelators (deferoxamine, deferiprone, Apo6619, and VK28) were evaluated again...
iofilm-associated infections caused by Acinetobacter baumannii are extremely recalcitrant to antibio...
Multidrug-resistant Acinetobacter baumannii poses a tremendous challenge to traditional antibiotic t...
Acinetobacter baumannii is a challenging pathogen due to antimicrobial resistance and biofilm develo...
Antimicrobial resistance is an incredibly pressing issue in modern medicine. Because of that many re...
The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with t...
While the occurrence and spread of antibiotic resistance in bacterial pathogens is vanishing curren...
Bacteremia caused by Acinetobacter baumannii is a highly lethal complication of hospital-acquired pn...
Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worl...
Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worl...
A paucity of effective, currently available antibiotics and a lull in antibiotic development pose si...
ESKAPE bacteria are a major cause of multidrug-resistant infections, and new drugs are urgently need...
ESKAPE bacteria are a major cause of multidrug-resistant infections, and new drugs are urgently need...
There are only few drugs available to treat fungal infections, and the lack of new antifungals, alon...
The activities of iron chelators (deferoxamine, deferiprone, Apo6619, and VK28) were evaluated again...
iofilm-associated infections caused by Acinetobacter baumannii are extremely recalcitrant to antibio...
Multidrug-resistant Acinetobacter baumannii poses a tremendous challenge to traditional antibiotic t...
Acinetobacter baumannii is a challenging pathogen due to antimicrobial resistance and biofilm develo...
Antimicrobial resistance is an incredibly pressing issue in modern medicine. Because of that many re...
The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with t...
While the occurrence and spread of antibiotic resistance in bacterial pathogens is vanishing curren...
Bacteremia caused by Acinetobacter baumannii is a highly lethal complication of hospital-acquired pn...
Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worl...
Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worl...
A paucity of effective, currently available antibiotics and a lull in antibiotic development pose si...
ESKAPE bacteria are a major cause of multidrug-resistant infections, and new drugs are urgently need...
ESKAPE bacteria are a major cause of multidrug-resistant infections, and new drugs are urgently need...
There are only few drugs available to treat fungal infections, and the lack of new antifungals, alon...
The activities of iron chelators (deferoxamine, deferiprone, Apo6619, and VK28) were evaluated again...
iofilm-associated infections caused by Acinetobacter baumannii are extremely recalcitrant to antibio...